Scopus BioPharma Inc. Annual Revenue from Contract with Customer, Excluding Assessed Tax in USD from 2019 to 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Scopus BioPharma Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from 2019 to 2022.
- Scopus BioPharma Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2023 was $0.000.
- Scopus BioPharma Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending March 31, 2023 was $0.000.
- Scopus BioPharma Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $0.000.
- Scopus BioPharma Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $0.000.
- Scopus BioPharma Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $0.000.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)